United Therapeutics (UTHR) Insider Trading & Ownership → POTUS in ‘25 Not Biden/Trump, But (From The Freeport Society) (Ad) Free UTHR Stock Alerts $274.26 +2.04 (+0.75%) (As of 05/17/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability United Therapeutics (NASDAQ:UTHR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$59.05 M Get UTHR Insider Trade Alerts Want to know when executives and insiders are buying or selling United Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address UTHR Insider Buying and Selling by Quarter Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. United Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/14/2024Christopher PatuskyDirectorSell1,310$264.35$346,298.50 5/13/2024Martine A RothblattCEOSell3,600$265.48$955,728.00 5/9/2024Martine A RothblattCEOSell3,600$264.22$951,192.00 5/6/2024Martine A RothblattCEOSell3,600$259.70$934,920.00 5/3/2024Christopher CauseyDirectorSell2,240$259.91$582,198.40 5/2/2024Martine A RothblattCEOSell3,600$258.09$929,124.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/30/2024Martine A RothblattCEOSell3,600$235.35$847,260.00 4/26/2024Martine A RothblattCEOSell3,600$235.20$846,720.00 4/24/2024Martine A RothblattCEOSell3,600$238.81$859,716.00 4/22/2024Martine A RothblattCEOSell3,600$236.47$851,292.00 4/18/2024Martine A RothblattCEOSell3,600$237.91$856,476.00 4/16/2024Martine A RothblattCEOSell3,600$232.05$835,380.00 4/12/2024Martine A RothblattCEOSell3,600$235.42$847,512.00 4/10/2024Martine A RothblattCEOSell13,800$237.27$3,274,326.00 4/8/2024Martine A RothblattCEOSell5,060$237.52$1,201,851.20 4/4/2024Martine A RothblattCEOSell15,000$233.27$3,499,050.00 4/4/2024Paul A MahonEVPSell6,000$232.37$1,394,220.00 3/28/2024Martine A RothblattCEOSell14,125$236.18$3,336,042.50 3/27/2024Nilda MesaDirectorSell325$237.80$77,285.00 3/26/2024Martine A RothblattCEOSell15,000$248.33$3,724,950.00 3/22/2024Martine A RothblattCEOSell15,000$237.05$3,555,750.00 3/21/2024Paul A MahonEVPSell6,000$236.45$1,418,700.00 3/19/2024Martine A RothblattCEOSell15,000$236.59$3,548,850.00 2/23/2024Christopher PatuskyDirectorSell1,680$224.00$376,320.00 2/15/2024Paul A MahonEVPSell6,000$215.31$1,291,860.00 2/1/2024Paul A MahonEVPSell6,000$215.01$1,290,060.00 1/18/2024Paul A MahonEVPSell6,000$218.72$1,312,320.00 1/4/2024Paul A MahonEVPSell6,000$227.97$1,367,820.00 12/21/2023Paul A MahonEVPSell6,000$229.27$1,375,620.00 12/19/2023Nilda MesaDirectorSell605$244.90$148,164.50 12/12/2023Christopher CauseyDirectorSell3,000$249.68$749,040.00 12/7/2023Paul A MahonEVPSell6,000$238.89$1,433,340.00 11/2/2023Paul A MahonEVPSell6,000$225.76$1,354,560.00 10/19/2023Paul A MahonEVPSell6,000$225.43$1,352,580.00 10/5/2023Paul A MahonEVPSell6,000$223.82$1,342,920.00 9/21/2023Paul A MahonEVPSell6,000$222.19$1,333,140.00 9/13/2023Nilda MesaDirectorSell383$222.36$85,163.88 9/7/2023Paul A MahonEVPSell6,000$222.98$1,337,880.00 8/3/2023Paul A MahonEVPSell6,000$236.25$1,417,500.00 7/20/2023Paul A MahonEVPSell2,500$243.87$609,675.00 The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now.7/6/2023Paul A MahonEVPSell6,000$215.19$1,291,140.00 6/15/2023Paul A MahonEVPSell6,000$227.77$1,366,620.00 6/1/2023Paul A MahonEVPSell6,000$209.11$1,254,660.00 5/18/2023Paul A MahonEVPSell6,000$214.58$1,287,480.00 (Data available from 1/1/2013 forward) UTHR Insider Trading Activity - Frequently Asked Questions Who is on United Therapeutics's Insider Roster? The list of insiders at United Therapeutics includes Christopher Causey, Christopher Patusky, Judy D Olian, Louis W Sullivan, Martine A Rothblatt, Nilda Mesa, Paul A Mahon, and Raymond Dwek. Learn more on insiders at UTHR. What percentage of United Therapeutics stock is owned by insiders? 12.50% of United Therapeutics stock is owned by insiders. Learn more on UTHR's insider holdings. Which United Therapeutics insiders have been buying company stock? The following insider purchased UTHR shares in the last 24 months: Christopher Patusky ($684.36). How much insider buying is happening at United Therapeutics? Insiders have purchased a total of 6 UTHR shares in the last 24 months for a total of $684.36 bought. Which United Therapeutics insiders have been selling company stock? The following insiders have sold UTHR shares in the last 24 months: Christopher Causey ($4,420,248.40), Christopher Patusky ($723,157.05), Judy D Olian ($284,820.00), Louis W Sullivan ($883,639.60), Martine A Rothblatt ($135,966,618.20), Nilda Mesa ($648,230.12), Paul A Mahon ($48,806,922.12), and Raymond Dwek ($521,186.40). How much insider selling is happening at United Therapeutics? Insiders have sold a total of 798,869 United Therapeutics shares in the last 24 months for a total of $192,254,821.89 sold. More Insider Trading Tools from MarketBeat Related Companies: BMRN Insider Selling IONS Insider Selling MDGL Insider Selling ALNY Insider Selling ALKS Insider Selling ARWR Insider Selling FOLD Insider Selling SRPT Insider Selling CTLT Insider Selling VTRS Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:UTHR) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
